RS&RS Scientific LTD’s Post

🏥 𝗠𝗶𝘁𝗵𝗶𝗹𝗮 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲 - 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗶𝗻 𝗣𝗮𝘁𝗻𝗮, 𝗕𝗶𝗵𝗮𝗿 🏥𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗖𝗵𝗲𝗺𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: 1. **Personalized Chemotherapy Plans**   🔹 Tailored treatment regimens based on each patient’s specific cancer type, stage, and health condition to ensure optimal outcomes. 2. **Expert Oncologists**     👨⚕️ Our highly skilled and experienced team of oncologists provides precise and effective chemotherapy, leveraging the latest medical advancements. 3. **Advanced Technology**     🔬 State-of-the-art chemotherapy equipment ensures accurate dosing and efficient treatment delivery, minimizing side effects. 4. **Holistic Patient Care**     🌿 Comprehensive support throughout the treatment journey, including nutritional guidance, psychological support, and side-effect management. 5. **Comfortable Treatment Environment**     🏥 We provide a serene, patient-friendly atmosphere during chemotherapy sessions, focusing on comfort and care. 6. **Minimizing Side Effects**     💊 We implement advanced protocols to manage and reduce the common side effects of chemotherapy, ensuring a smoother recovery process. 7. **Continuous Monitoring & Support**     📈 Ongoing assessment of the patient’s response to chemotherapy, with adjustments made as needed for the best outcomes. 🌟 **Mithila Cancer Care** is dedicated to providing compassionate and cutting-edge chemotherapy treatment, ensuring the highest level of care and support for every patient. 𝗗𝗿. 𝗔𝘃𝗶𝗻𝗮𝘀𝗵 𝗨𝗽𝗮𝗱𝗵𝘆𝗮𝘆 𝗖𝗮𝗻𝗰𝗲𝗿 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁 𝗡𝗲𝗮𝗿 𝗜𝗚𝗜𝗠𝗦, 𝗣𝗶𝗹𝗹𝗲𝗿 𝗡𝗼.𝟲𝟱, 𝗥𝗮𝗷𝗮 𝗕𝗮𝘇𝗮𝗮𝗿, 𝗕𝗮𝗶𝗹𝗲𝘆 𝗥𝗼𝗮𝗱, 𝗣𝗮𝘁𝗻𝗮, 𝗕𝗶𝗵𝗮𝗿. 𝗕𝗼𝗼𝗸 𝗔𝗽𝗽𝗼𝗶𝗻𝘁𝗺𝗲𝗻𝘁 : 𝟵𝟭𝟰𝟮𝟬𝟭𝟳𝟭𝟴𝟵. #FightCancer #Oncology #CancerSupport #CancerSurvivor #CancerResearch #ChemoCare #Chemotherapy #RadiationTherapy #TargetedTherapy #Immunotherapy #HeadAndNeckCancer #BreastCancer #LungCancer #ProstateCancer #ColorectalCancer #CancerHospital #AdvancedCancerCare #MithilaCancerCare #PatnaHealthcare #CancerFighter #CancerWarrior #BeatCancer #CancerHealing

With limited treatment options, and no curative treatments, clinical trials are an important avenue for many people with metastatic breast cancer. But trials can too often perpetuate broader societal inequities, which limits our understanding of how certain medical interventions affect different groups of people. We need action across multiple levels of clinical trial design and implementation to embed more equitable and inclusive practices. Achieving this can improve health outcomes for all. https://lnkd.in/eRXb4Gke

The NHS Long Term Plan's focus on increasing bowel cancer screening through colonoscopy is a positive step towards better healthcare outcomes. The long-term plan aims to improve early cancer diagnosis across various types, including bowel cancer. Its ambition is to have 75% of all cancers diagnosed at stage 1 or 2 by 2028. However, this also highlights the ongoing challenge of workforce strain in the endoscopy sector and The Royal College of Physicians estimates a shortage of over 1,000 consultant gastroenterologists in the UK, impacting access to vital services like colonoscopies. We understand the vital role endoscopy plays in early diagnosis and treatment. That's why we offer a reliable endoscopy service as part of our comprehensive clinical insourcing solutions. If you would like to find out more, contact us using: ✉️ info@healthnow.co.uk 📞0203 343 5971 #Healthcare #Endoscopy #EarlyDetection #NHS #MedicalInsourcing

𝗡𝗜𝗖𝗘 𝗶𝗻 𝗨𝗞 𝗲𝘅𝘁𝗲𝗻𝗱𝘀 𝘁𝗵𝗲 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗘𝗻𝗱𝗼𝗣𝗿𝗲𝗱𝗶𝗰𝘁® 𝘁𝗼 𝗟𝘆𝗺𝗽𝗵 𝗻𝗼𝗱𝗲 𝗽𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗘𝗥+ 𝗛𝗘𝗥𝟮- 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗘𝗮𝗿𝗹𝘆 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 Exciting news from Myriad Genetics: In the new review of its diagnostics guidance DG34, the NICE - National Institute for Health and Care Excellence (NICE) has expanded its recommendation for EndoPredict® to now include postmenopausal, lymph node positive, early-stage breast cancer patients. This marks a significant step in personalized healthcare, offering hope to a wider range of patients with specific #breastcancer profiles. 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝗖𝗮𝗿𝗲: Facilitates decisions about adjuvant chemotherapy for patients with 1–3 positive lymph nodes, enhancing outcomes. 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗰 & 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗔𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲: By using EndoPredict the number of patients on chemotherapy can be reduced avoiding cost and side effects. 𝗥𝗮𝗽𝗶𝗱 𝗥𝗲𝘀𝘂𝗹𝘁𝘀: EndoPredict® delivers swift, accurate diagnostics with a turn-around-time of 3–5 days, enabling quicker decision-making. 𝗖𝗼𝘀𝘁-𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀: EndoPredict® is likely to be cost-effective when used to guide adjuvant chemotherapy decision making with postmenopausal women. Apostolos Siscoglou, General Manager EU and LATAM at Myriad Genetics, comments on the endorsement's significance: "𝘛𝘩𝘪𝘴 𝘨𝘶𝘪𝘥𝘢𝘯𝘤𝘦 𝘩𝘪𝘨𝘩𝘭𝘪𝘨𝘩𝘵𝘴 #𝘌𝘯𝘥𝘰𝘗𝘳𝘦𝘥𝘪𝘤𝘵'𝘴 𝘳𝘰𝘭𝘦 𝘪𝘯 𝘤𝘰𝘴𝘵-𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦, 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘤𝘢𝘳𝘦, 𝘴𝘶𝘱𝘱𝘰𝘳𝘵𝘪𝘯𝘨 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘪𝘯 𝘮𝘢𝘬𝘪𝘯𝘨 𝘪𝘯𝘧𝘰𝘳𝘮𝘦𝘥 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯𝘴." This endorsement not only underscores our commitment to advancing personalized medicine but also encourages a shift towards more targeted, efficient #patientcare. Let's discuss how this development can shape the future of breast cancer treatment. The NICE Diagnostics guidance [DG58] can be found here: https://lnkd.in/gKtkfTsM #MyriadGenetics #BreastCancerAwareness #PrecisionMedicine #HealthcareInnovation

Cost of Cancer Treatment to come down...Tata Institute of Fundamental Research (TIFR) & TATA MEMORIAL HOSPITAL have made a break through recovery with their decade long research. A tablet for Rs.100 ....just at a dollar plus cents that can: 1) Prevent recurrence of cancer 2) Reduce the side effects of treatments like radiation and chemo by 50% ! 3) Human trails are awaited 4) This could be used in Pancreatic, lung and oral cancers The treatment costing lakhs can come down to thousands and rupees ... Hats off to the Institution and the researchers.... #healthcarecosts #healthcaremanagement #healthcare #cancercare #cancertreatment #cancerprevention #cancerresearch

Small #nudge big impact. How do #healthcare nedges can improve the health outcomes? Here is an example of #lungcancer screening. https://lnkd.in/eNXNpbP2 Nudges have maximum impact when there is an equitable #access. An example of #prostate #cancer #screening #jama https://lnkd.in/ewd5ikMK https://lnkd.in/eNXNpbP2

Better sooner than later. 🖊 This is a case from practice. A man with no health complaints. A lung nodule is interpreted as LungRADS2. After 6 months - the lesion has doubled in size. It wasn't lung cancer. Metastasis. Clinical examination reveals colorectal cancer. Yes, cancer, but better sooner than later. 💠 Lung cancer prevention is crucial, and LungRADS (Lung Imaging Reporting and Data System) is a key tool in this effort. LungRADS is a standardized system for reporting and classifying low-dose CT (LDCT) chest scans in lung cancer screening programs. Developed by the American College of Radiology (ACR), it enhances diagnostic accuracy and consistency. Benefits : ◻ Early Detection: Helps identify lung cancer early, significantly improving treatment outcomes. ◻ Reduced False Positives: Minimizes unnecessary follow-ups, reducing patient stress and costs. ◻ Improved Standards: Ensures consistent interpretation of LDCT results, aiding in accurate and swift decisions. ◻ Research and Protocols: Provides standardized data beneficial for research and enhancing treatment standards. Implementing LungRADS is a significant step forward in lung cancer (not only!!) diagnosis and treatment. Its effective use can save lives and improve healthcare quality. #LungCancer #EarlyDetection #LungRADS #Radiology #MedicalImaging #PatientCare

In the latest issue of the Journal of Clinical Pathways, Poka Cui, Peter Blanshard, María Teresa Campos, Adrien Moucquot, S. Hassan N., David Dellamonica, and Heather Moses completed a literature review along with interviews involving lung cancer multidisciplinary teams (MDTMs) from 24 medical centers across Europe and Canada to identify best practices and develop a self-assessment toolkit for MDTMs. "The report discusses how these results should be used to self-optimize hospital MDTs, promote standardization, and encourage increased cross-hospital best practices sharing. With this, MDTs will be better positioned to deliver on the key goal of improved patient outcomes while promoting equality of access to health care," said the authors. Read the full report here: https://lnkd.in/g5jz8Mdk #JournalOfClinicalPathways #ValueBasedCare #StandardOfCare #CancerCare #LungCancer #MultidisciplinaryTeams #BestPractices #ResearchReports

An exciting development in preventive healthcare - a new self-screening tool for cervical cancer! As someone who has had cervical cancer, I know firsthand how crucial early detection is. This new test option will mitigate barriers for patients and facilitate earlier diagnosis, ultimately reducing the need for more intensive treatment. If you are among the 25% of US women that are overdue for a cervical cancer screening, use my experience as an excuse to schedule an appointment with your healthcare provider! #Healthcare #CervicalCancer #EarlyDetection #PreventiveHealthcare #Health #HealthInnovation #Prevention #Preventive

Liquid biopsy's rapid rise, especially ctDNA detection, is revolutionizing cancer care with its non-invasive approach, quick results, and real-time monitoring. MRD, a key to tumor recurrence and prognosis, is now more detectable than ever. A study in NSCLC patients post-treatment shows ctDNA can predict recurrence risk, guiding personalized care. https://lnkd.in/g4YKmZWP Another highlights ctDNA's role in prognosis and treatment response, offering crucial insights for patient outcomes. https://lnkd.in/gng6dG5i Key ctDNA benefits in MRD detection: -Early Recurrence Alerts: ctDNA detects cancer relapse early, enabling timely interventions. -Tailored Treatments: ctDNA guides personalized treatment plans for improved outcomes. -Treatment Monitoring: ctDNA tracks patient responses, aiding in treatment adjustments. -Prognostic Insight: ctDNA helps assess disease progression risk. -Efficient Treatment: ctDNA prevents unnecessary treatments, saving resources. In summary, the application of ctDNA NGS detection in MRD provides important clinical information for cancer patients, contributing to precision medicine and improving patient treatment outcomes. #LiquidBiopsy #ctDNA #CancerDetection #PrecisionMedicine #MRD #NSCLC #TreatmentMonitoring